silybin has been researched along with Lymph Node Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bousserouel, S; Gossé, F; Kauntz, H; Raul, F | 1 |
| Chang, LS; Chen, YL; Gao, Y; He, D; Li, L; Liang, L; Wang, XY; Wang, ZQ; Zeng, J | 1 |
2 other study(ies) available for silybin and Lymph Node Metastasis
| Article | Year |
|---|---|
The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Colonic Neoplasms; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Humans; Lymphatic Metastasis; Membrane Potential, Mitochondrial; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Silybin; Silymarin; TNF-Related Apoptosis-Inducing Ligand; Transcription, Genetic; X-Linked Inhibitor of Apoptosis Protein | 2012 |
Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Screening Assays, Antitumor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Humans; Kidney Neoplasms; Lymphatic Metastasis; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Phosphorylation; Protein Processing, Post-Translational; Signal Transduction; Silybin; Silymarin | 2012 |